カテゴリー： Market Monitor Global, 世界, 医療/バイオ

生物製剤アウトソーシングフォーミュレーションサービスのグローバル市場展望 2023年-2029年：分析試験、プロセス開発、セル開発、cGMP製造、その他

◆英語タイトル：Biologics Outsourcing Formulation Services Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC12268）◆商品コード：MMG23DC12268
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月
◆ページ数：100
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の生物製剤アウトソーシングフォーミュレーションサービス市場規模と予測を収録しています。・世界の生物製剤アウトソーシングフォーミュレーションサービス市場：売上、2018年-2023年、2024年-2029年
・世界の生物製剤アウトソーシングフォーミュレーションサービス市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の生物製剤アウトソーシングフォーミュレーションサービス市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「分析試験」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

生物製剤アウトソーシングフォーミュレーションサービスのグローバル主要企業は、AtbbVie、 Thermo Fisher Scientific、 Boehringer Ingelheim International、 GenScript、 Merck、 Lonza Group、 Catalent、 Innovent Biologics、 Syngene、 Shanghai Medicilon、 GL Biochem Corporation、 GVK Biosciences Private、 Horizon Discovery Group、 Selexis、 Abzena、 Adimabなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、生物製剤アウトソーシングフォーミュレーションサービスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の生物製剤アウトソーシングフォーミュレーションサービス市場：タイプ別、2018年-2023年、2024年-2029年
世界の生物製剤アウトソーシングフォーミュレーションサービス市場：タイプ別市場シェア、2022年
・分析試験、プロセス開発、セル開発、cGMP製造、その他

世界の生物製剤アウトソーシングフォーミュレーションサービス市場：用途別、2018年-2023年、2024年-2029年
世界の生物製剤アウトソーシングフォーミュレーションサービス市場：用途別市場シェア、2022年
・幹細胞研究、ワクチン開発、組織関連製品開発、その他

世界の生物製剤アウトソーシングフォーミュレーションサービス市場：地域・国別、2018年-2023年、2024年-2029年
世界の生物製剤アウトソーシングフォーミュレーションサービス市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における生物製剤アウトソーシングフォーミュレーションサービスのグローバル売上、2018年-2023年
・主要企業における生物製剤アウトソーシングフォーミュレーションサービスのグローバル売上シェア、2022年
・主要企業における生物製剤アウトソーシングフォーミュレーションサービスのグローバル販売量、2018年-2023年
・主要企業における生物製剤アウトソーシングフォーミュレーションサービスのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
AtbbVie、 Thermo Fisher Scientific、 Boehringer Ingelheim International、 GenScript、 Merck、 Lonza Group、 Catalent、 Innovent Biologics、 Syngene、 Shanghai Medicilon、 GL Biochem Corporation、 GVK Biosciences Private、 Horizon Discovery Group、 Selexis、 Abzena、 Adimab

*************************************************************

・調査・分析レポートの概要
生物製剤アウトソーシングフォーミュレーションサービス市場の定義
市場セグメント
世界の生物製剤アウトソーシングフォーミュレーションサービス市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の生物製剤アウトソーシングフォーミュレーションサービス市場規模
世界の生物製剤アウトソーシングフォーミュレーションサービス市場規模：2022年 VS 2029年
世界の生物製剤アウトソーシングフォーミュレーションサービス市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの生物製剤アウトソーシングフォーミュレーションサービスの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の生物製剤アウトソーシングフォーミュレーションサービス製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：分析試験、プロセス開発、セル開発、cGMP製造、その他
生物製剤アウトソーシングフォーミュレーションサービスのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：幹細胞研究、ワクチン開発、組織関連製品開発、その他
生物製剤アウトソーシングフォーミュレーションサービスの用途別グローバル売上・予測

・地域別市場分析
地域別生物製剤アウトソーシングフォーミュレーションサービス市場規模 2022年と2029年
地域別生物製剤アウトソーシングフォーミュレーションサービス売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
AtbbVie、 Thermo Fisher Scientific、 Boehringer Ingelheim International、 GenScript、 Merck、 Lonza Group、 Catalent、 Innovent Biologics、 Syngene、 Shanghai Medicilon、 GL Biochem Corporation、 GVK Biosciences Private、 Horizon Discovery Group、 Selexis、 Abzena、 Adimab
...

This research report provides a comprehensive analysis of the Biologics Outsourcing Formulation Services market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Biologics Outsourcing Formulation Services market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Biologics Outsourcing Formulation Services, challenges faced by the industry, and potential opportunities for market players.
The global Biologics Outsourcing Formulation Services market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Biologics Outsourcing Formulation Services market presents opportunities for various stakeholders, including Stem Cell Research, Vaccine Development. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Biologics Outsourcing Formulation Services market. Additionally, the growing consumer demand present avenues for market expansion.
The global Biologics Outsourcing Formulation Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Biologics Outsourcing Formulation Services market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Biologics Outsourcing Formulation Services market.
Market Overview: The report provides a comprehensive overview of the Biologics Outsourcing Formulation Services market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Analytical Testing, Process Development), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Biologics Outsourcing Formulation Services market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Biologics Outsourcing Formulation Services market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Biologics Outsourcing Formulation Services market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Biologics Outsourcing Formulation Services market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Biologics Outsourcing Formulation Services market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Biologics Outsourcing Formulation Services market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Biologics Outsourcing Formulation Services, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Biologics Outsourcing Formulation Services market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Biologics Outsourcing Formulation Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Analytical Testing
Process Development
Cell Development
cGMP Manufacturing
Others
Market segment by Application
Stem Cell Research
Vaccine Development
Tissue Related Products Development
Others
Global Biologics Outsourcing Formulation Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
AtbbVie
Thermo Fisher Scientific
Boehringer Ingelheim International
GenScript
Merck
Lonza Group
Catalent
Innovent Biologics
Syngene
Shanghai Medicilon
GL Biochem Corporation
GVK Biosciences Private
Horizon Discovery Group
Selexis
Abzena
Adimab
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biologics Outsourcing Formulation Services, market overview.
Chapter 2: Global Biologics Outsourcing Formulation Services market size in revenue.
Chapter 3: Detailed analysis of Biologics Outsourcing Formulation Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biologics Outsourcing Formulation Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Biologics Outsourcing Formulation Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biologics Outsourcing Formulation Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biologics Outsourcing Formulation Services Overall Market Size
2.1 Global Biologics Outsourcing Formulation Services Market Size: 2022 VS 2029
2.2 Global Biologics Outsourcing Formulation Services Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biologics Outsourcing Formulation Services Players in Global Market
3.2 Top Global Biologics Outsourcing Formulation Services Companies Ranked by Revenue
3.3 Global Biologics Outsourcing Formulation Services Revenue by Companies
3.4 Top 3 and Top 5 Biologics Outsourcing Formulation Services Companies in Global Market, by Revenue in 2022
3.5 Global Companies Biologics Outsourcing Formulation Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biologics Outsourcing Formulation Services Players in Global Market
3.6.1 List of Global Tier 1 Biologics Outsourcing Formulation Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Biologics Outsourcing Formulation Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Biologics Outsourcing Formulation Services Market Size Markets, 2022 & 2029
4.1.2 Analytical Testing
4.1.3 Process Development
4.1.4 Cell Development
4.1.5 cGMP Manufacturing
4.1.6 Others
4.2 By Type – Global Biologics Outsourcing Formulation Services Revenue & Forecasts
4.2.1 By Type – Global Biologics Outsourcing Formulation Services Revenue, 2018-2023
4.2.2 By Type – Global Biologics Outsourcing Formulation Services Revenue, 2024-2029
4.2.3 By Type – Global Biologics Outsourcing Formulation Services Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Biologics Outsourcing Formulation Services Market Size, 2022 & 2029
5.1.2 Stem Cell Research
5.1.3 Vaccine Development
5.1.4 Tissue Related Products Development
5.1.5 Others
5.2 By Application – Global Biologics Outsourcing Formulation Services Revenue & Forecasts
5.2.1 By Application – Global Biologics Outsourcing Formulation Services Revenue, 2018-2023
5.2.2 By Application – Global Biologics Outsourcing Formulation Services Revenue, 2024-2029
5.2.3 By Application – Global Biologics Outsourcing Formulation Services Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Biologics Outsourcing Formulation Services Market Size, 2022 & 2029
6.2 By Region – Global Biologics Outsourcing Formulation Services Revenue & Forecasts
6.2.1 By Region – Global Biologics Outsourcing Formulation Services Revenue, 2018-2023
6.2.2 By Region – Global Biologics Outsourcing Formulation Services Revenue, 2024-2029
6.2.3 By Region – Global Biologics Outsourcing Formulation Services Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Biologics Outsourcing Formulation Services Revenue, 2018-2029
6.3.2 US Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.3.3 Canada Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.3.4 Mexico Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Biologics Outsourcing Formulation Services Revenue, 2018-2029
6.4.2 Germany Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.4.3 France Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.4.4 U.K. Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.4.5 Italy Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.4.6 Russia Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.4.7 Nordic Countries Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.4.8 Benelux Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Biologics Outsourcing Formulation Services Revenue, 2018-2029
6.5.2 China Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.5.3 Japan Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.5.4 South Korea Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.5.5 Southeast Asia Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.5.6 India Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Biologics Outsourcing Formulation Services Revenue, 2018-2029
6.6.2 Brazil Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.6.3 Argentina Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Biologics Outsourcing Formulation Services Revenue, 2018-2029
6.7.2 Turkey Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.7.3 Israel Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.7.4 Saudi Arabia Biologics Outsourcing Formulation Services Market Size, 2018-2029
6.7.5 UAE Biologics Outsourcing Formulation Services Market Size, 2018-2029
7 Biologics Outsourcing Formulation Services Companies Profiles
7.1 AtbbVie
7.1.1 AtbbVie Company Summary
7.1.2 AtbbVie Business Overview
7.1.3 AtbbVie Biologics Outsourcing Formulation Services Major Product Offerings
7.1.4 AtbbVie Biologics Outsourcing Formulation Services Revenue in Global Market (2018-2023)
7.1.5 AtbbVie Key News & Latest Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Biologics Outsourcing Formulation Services Major Product Offerings
7.2.4 Thermo Fisher Scientific Biologics Outsourcing Formulation Services Revenue in Global Market (2018-2023)
7.2.5 Thermo Fisher Scientific Key News & Latest Developments
7.3 Boehringer Ingelheim International
7.3.1 Boehringer Ingelheim International Company Summary
7.3.2 Boehringer Ingelheim International Business Overview
7.3.3 Boehringer Ingelheim International Biologics Outsourcing Formulation Services Major Product Offerings
7.3.4 Boehringer Ingelheim International Biologics Outsourcing Formulation Services Revenue in Global Market (2018-2023)
7.3.5 Boehringer Ingelheim International Key News & Latest Developments
7.4 GenScript
7.4.1 GenScript Company Summary
7.4.2 GenScript Business Overview
7.4.3 GenScript Biologics Outsourcing Formulation Services Major Product Offerings
7.4.4 GenScript Biologics Outsourcing Formulation Services Revenue in Global Market (2018-2023)
7.4.5 GenScript Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Biologics Outsourcing Formulation Services Major Product Offerings
7.5.4 Merck Biologics Outsourcing Formulation Services Revenue in Global Market (2018-2023)
7.5.5 Merck Key News & Latest Developments
7.6 Lonza Group
7.6.1 Lonza Group Company Summary
7.6.2 Lonza Group Business Overview
7.6.3 Lonza Group Biologics Outsourcing Formulation Services Major Product Offerings
7.6.4 Lonza Group Biologics Outsourcing Formulation Services Revenue in Global Market (2018-2023)
7.6.5 Lonza Group Key News & Latest Developments
7.7 Catalent
7.7.1 Catalent Company Summary
7.7.2 Catalent Business Overview
7.7.3 Catalent Biologics Outsourcing Formulation Services Major Product Offerings
7.7.4 Catalent Biologics Outsourcing Formulation Services Revenue in Global Market (2018-2023)
7.7.5 Catalent Key News & Latest Developments
7.8 Innovent Biologics
7.8.1 Innovent Biologics Company Summary
7.8.2 Innovent Biologics Business Overview
7.8.3 Innovent Biologics Biologics Outsourcing Formulation Services Major Product Offerings
7.8.4 Innovent Biologics Biologics Outsourcing Formulation Services Revenue in Global Market (2018-2023)
7.8.5 Innovent Biologics Key News & Latest Developments
7.9 Syngene
7.9.1 Syngene Company Summary
7.9.2 Syngene Business Overview
7.9.3 Syngene Biologics Outsourcing Formulation Services Major Product Offerings
7.9.4 Syngene Biologics Outsourcing Formulation Services Revenue in Global Market (2018-2023)
7.9.5 Syngene Key News & Latest Developments
7.10 Shanghai Medicilon
7.10.1 Shanghai Medicilon Company Summary
7.10.2 Shanghai Medicilon Business Overview
7.10.3 Shanghai Medicilon Biologics Outsourcing Formulation Services Major Product Offerings
7.10.4 Shanghai Medicilon Biologics Outsourcing Formulation Services Revenue in Global Market (2018-2023)
7.10.5 Shanghai Medicilon Key News & Latest Developments
7.11 GL Biochem Corporation
7.11.1 GL Biochem Corporation Company Summary
7.11.2 GL Biochem Corporation Business Overview
7.11.3 GL Biochem Corporation Biologics Outsourcing Formulation Services Major Product Offerings
7.11.4 GL Biochem Corporation Biologics Outsourcing Formulation Services Revenue in Global Market (2018-2023)
7.11.5 GL Biochem Corporation Key News & Latest Developments
7.12 GVK Biosciences Private
7.12.1 GVK Biosciences Private Company Summary
7.12.2 GVK Biosciences Private Business Overview
7.12.3 GVK Biosciences Private Biologics Outsourcing Formulation Services Major Product Offerings
7.12.4 GVK Biosciences Private Biologics Outsourcing Formulation Services Revenue in Global Market (2018-2023)
7.12.5 GVK Biosciences Private Key News & Latest Developments
7.13 Horizon Discovery Group
7.13.1 Horizon Discovery Group Company Summary
7.13.2 Horizon Discovery Group Business Overview
7.13.3 Horizon Discovery Group Biologics Outsourcing Formulation Services Major Product Offerings
7.13.4 Horizon Discovery Group Biologics Outsourcing Formulation Services Revenue in Global Market (2018-2023)
7.13.5 Horizon Discovery Group Key News & Latest Developments
7.14 Selexis
7.14.1 Selexis Company Summary
7.14.2 Selexis Business Overview
7.14.3 Selexis Biologics Outsourcing Formulation Services Major Product Offerings
7.14.4 Selexis Biologics Outsourcing Formulation Services Revenue in Global Market (2018-2023)
7.14.5 Selexis Key News & Latest Developments
7.15 Abzena
7.15.1 Abzena Company Summary
7.15.2 Abzena Business Overview
7.15.3 Abzena Biologics Outsourcing Formulation Services Major Product Offerings
7.15.4 Abzena Biologics Outsourcing Formulation Services Revenue in Global Market (2018-2023)
7.15.5 Abzena Key News & Latest Developments
7.16 Adimab
7.16.1 Adimab Company Summary
7.16.2 Adimab Business Overview
7.16.3 Adimab Biologics Outsourcing Formulation Services Major Product Offerings
7.16.4 Adimab Biologics Outsourcing Formulation Services Revenue in Global Market (2018-2023)
7.16.5 Adimab Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 生物製剤アウトソーシングフォーミュレーションサービスのグローバル市場展望 2023年-2029年：分析試験、プロセス開発、セル開発、cGMP製造、その他(Biologics Outsourcing Formulation Services Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 脂質ナノ粒子（LNP）製造装置のグローバル市場展望 2023年-2029年：小型LNP製造設備、大型LNP製造設備
  • 化粧品用活性ペプチドのグローバル市場展望 2023年-2029年：ヘキサペプチド、コラーゲンペプチド、その他
  • カスタムアデノ随伴ウイルスベクター作製サービスのグローバル市場展望 2023年-2029年：小規模、中規模、大規模
  • 足＆足首用同種移植片のグローバル市場展望 2023年-2029年：同種移植ウェッジ、同種移植腱、同種移植無細胞真皮マトリックス、軟骨同種移植マトリックス、同種皮膚移植
  • 乳幼児用混合ワクチンのグローバル市場展望 2023年-2029年：5種混合ワクチン、4種混合ワクチン、3種混合ワクチン、その他